Hikma Pharmaceuticals plc Financials

Market Capitalization £4.34 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	16.67
Forward PE	11.05
Price to Sales TTM	£1.39
Price to Book MRQ	£187.71
Enterprise to Revenue	1.75
Enterprise to EBITDA	6.97

Financial Reports as of Jun. 30, 2019

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2019-06-30
Profit Margin	11.48%
Operating Margin	13.22%
Return on Assets TTM	7.75%
Return on Equity TTM	15.98%

Income Statement

Revenue TTM	£2,290,339,895
Revenue per Share TTM	£14.13
Quarterly Revenue Growth	7.60%
Gross Profit TTM	£1,036,402,632
EBITDA	£784,000,000
Net Income to Common TTM	£262,945,956
Diluted EPS TTM	£1.18
Quarterly Earnings Growth YoY	125.40%

Balance Sheet

Total Cash MRQ	£156,009,717
Total Cash per Share MRQ	£0.97
Total Debt MRQ	£
Total Debt to Equity MRQ	56.27
Current Ratio MRQ	1.14
Book Value per Share MRQ	£10.48

Cash Flow

Operating Cash Flow TTM	£413,096,154
Levered Free Cash Flow TTM	£212,499,146

HIK Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	220,431,263
Float Shares	153,395,912
Avg 10 Volume	382,969
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	30.37%
% Held by Institutions	37.79%

Stock Price Summary

Beta	0.66
Fifty Two Week Low	£1751.00
Fifty Two Week High	£2360.00
Fifty Two Week Change	8.14%
Day 50 MA	£2048.40
Day 200 MA	£2017.73

Dividends and Splits

Forward Annual Dividend Rate	£74.29
Forward Annual Dividend Yield	3.75%
Trailing Annual Dividend Rate	£66.67
Trailing Annual Dividend Yield	3.37%
Payout Ratio	48.91%
Dividend Date
Ex Dividend Date	2025-03-20
Last Split Factor
Last Split Date